Literature DB >> 133026

Benign intracranial hypertension due to A-hypervitaminosis in adults and adolescents.

A Lombaert, H Carton.   

Abstract

Three new cases of chronic vitamin A intoxication are reported and a review of the literature with special reference to chronic intoxication in adolescents and adults is presented. The most prominent features are intracranial hypertension, skin and hair deviations, pain in the musculoskeletal system, and fatigue. Intracranial hypertension occurs in 50% of chronic intoxications, but is not invariably linked with the other symptoms. Young women are the major age group represented. There seems to be no relation between the severity of the clinical picture and the vitamin A serum level. Discontinuance of vitamin A intake is sufficient for cure.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 133026     DOI: 10.1159/000114758

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  5 in total

1.  Seventh nerve palsy as a false localizing sign in benign intracranial hypertension.

Authors:  Christopher Kearsey; Prabhath Fernando; Hani T S Benamer; Harit Buch
Journal:  J R Soc Med       Date:  2010-09-09       Impact factor: 5.344

2.  Role of vitamin A metabolism in IIH: Results from the idiopathic intracranial hypertension treatment trial.

Authors:  J Libien; M J Kupersmith; W Blaner; M P McDermott; S Gao; Y Liu; J Corbett; M Wall
Journal:  J Neurol Sci       Date:  2016-11-10       Impact factor: 3.181

Review 3.  Adverse ocular reactions to drugs.

Authors:  M A Spiteri; D G James
Journal:  Postgrad Med J       Date:  1983-06       Impact factor: 2.401

Review 4.  Retinoic acid and affective disorders: the evidence for an association.

Authors:  J Douglas Bremner; Kirsty D Shearer; Peter J McCaffery
Journal:  J Clin Psychiatry       Date:  2011-08-23       Impact factor: 4.384

Review 5.  The neurobiology of retinoic acid in affective disorders.

Authors:  J Douglas Bremner; Peter McCaffery
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2007-07-10       Impact factor: 5.067

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.